Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
Key facts
- Who runs it
- Children's Hospital of Philadelphia
- Where
- Atlanta, Baltimore, Philadelphia, and St Louis, United StatesSee the 4 sites
- Trial code
- Status
- Recruiting
- People taking part
- 52,500 people, planned
- Started
- 21 Aug 2023
- Planned end
- May 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Multifaceted de-implementation strategy to reduce vancomycin overuse
- Record updated
- 19 September 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Other criteria
- Patient Inclusion Criteria:
- Admitted to one of the participating PICUs during the study period; Patient Exclusion Criteria:
- None; Clinician Inclusion Criteria:
- PICU prescribing clinician (including attending physicians, fellows, residents, nurse practitioners, and physician assistants) OR sepsis stakeholder (leader of sepsis quality improvement work, medical director) at one of the participating sites at the time the survey is deployed
- Age ≥ 18 years old
- Employed by one of the participating sites; Clinician Exclusion Criteria:
- Volunteers or other non-employee hospital staff
- Limited English proficiency
This trial is currently available in United States.
- Children's Healthcare of AtlantaAtlanta, United StatesContact: Preeti Jaggi, MDTaking people
- Johns Hopkins Children's CenterBaltimore, United StatesContact: Pranita Tamma, MD, MPHTaking people
- Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Kathleen Chiotos, MD, MSCETaking people
- St. Louis Children's HospitalSt Louis, United StatesContact: Evan Facer, DOTaking people
About the trial
What the trial wants to find out
The goal of this quasi-experimental interventional study is to determine the effectiveness of a multifaceted stewardship intervention in reducing overall vancomycin use in five tertiary care Pediatric Intensive Care Units (PICU).
Read full original descriptionShow less
There are two groups of subjects in this study: PICU clinicians/sepsis stakeholders and patients admitted to one of the participating PICUs during the study period. The intervention will at a minimum include:
* Implementation of a clinical guideline indicating when vancomycin should and should not be used * Unit-level feedback on overall vancomycin use within and across centers * Clinician education.
The 2 groups in the trial
- PICU Clinicians and Sepsis stakeholdersOther group
Clinicians and sepsis stakeholders in the participating sites will be primarily recruited via email. During the course of this multifaceted intervention: * All the PICU (Pediatric Intensive Care Unit) prescribing clinicians and sepsis stakeholders in the participating sites will receive clinical guidelines, unit-level feedback reports, and education on Vancomycin use during the intervention. * Investigators will perform semi-structured interviews with 90 PICU clinicians and sepsis stakeholders. * Surveys will be sent to all eligible clinicians, estimated to be up to 2500 individuals across the 4 sites. These structured surveys will be done at baseline and at 9 months post-implementation.
Treatment: Multifaceted de-implementation strategy to reduce vancomycin overuse
- PICU Patients with suspected sepsisNo study treatment, for comparison
Research procedures involving patients will be limited to medical record review. This medical record review will help inform the intervention directed at PICU clinicians/stakeholders and the assessment of study outcomes. Approximately 50,000 patients will participate in the study. Data elements will be collected at each site and stored as password-protected Comma-separated values (CSV) files. These files will not contain any direct Protected Health Information (PHI) but will contain elements of date (e.g., date of admission, date of suspected sepsis episode). The study Identification (ID) number will be used to identify each unique patient. Each site will collect and store data in compliance with the Children's Hospital of Philadelphia (CHOP) and local Institutional Review Board (IRB) policies.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis (REVAMP-Sepsis)
- Record updated
- 19 September 2025